GALLIUM CITRATE GA 67 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gallium Citrate Ga 67, and when can generic versions of Gallium Citrate Ga 67 launch?
Gallium Citrate Ga 67 is a drug marketed by Curium, Ge Healthcare, and Lantheus Medcl. and is included in three NDAs.
The generic ingredient in GALLIUM CITRATE GA 67 is gallium citrate ga-67. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium citrate ga-67 profile page.
Summary for GALLIUM CITRATE GA 67
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 9 |
Patent Applications: | 63 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GALLIUM CITRATE GA 67 at DailyMed |
Recent Clinical Trials for GALLIUM CITRATE GA 67
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Bordeaux | Phase 2 |
Rahul Aggarwal | Phase 2 |
Merck Sharp & Dohme Corp. | Phase 2 |
US Patents and Regulatory Information for GALLIUM CITRATE GA 67
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Curium | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 018058-001 | Approved Prior to Jan 1, 1982 | BS | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ge Healthcare | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 017700-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lantheus Medcl | GALLIUM CITRATE GA 67 | gallium citrate ga-67 | INJECTABLE;INJECTION | 017478-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |